Professur für Innere Medizin mit dem Schwerpunkt Immundefizienz

ROS is the boss (2017) Hahn J, Kienhofer D, Stoof J, Csepregi JZ, Reinwald C, Maueröder C, Urbonaviciute V, et al. Conference contribution T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients (2016) Mummert C, Hofmann C, Hueckelhoven AG, Bergmann S, Mueller-Schmucker SM, Harrer EG, Dörrie J, et al. Journal article Sequence-function analysis of three T cell receptors targeting the HIV-1 p17 (2016) Mummert C, Hofmann C, Hueckelhoven AG, Bergmann S, Müller-Schmucker S, Harrer EG, Dörrie J, et al. Conference contribution HIV Nef- and Notch1-dependent Endocytosis of ADAM17 Induces Vesicular TNF Secretion in Chronic HIV Infection (2016) Ostalecki C, Wittki S, Lee JH, Geist MM, Tibroni N, Harrer T, Schuler G, et al. Journal article Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies (2016) Borte M, Krivan G, Derfalvi B, Marodi L, Harrer T, Jolles S, Bourgeois C, et al. Journal article Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation (2016) Wedmann R, Onderka C, Wei S, Szijarto IA, Miljkovic J, Mitrovic A, Lange M, et al. Journal article A Multiplex Kindred with Hennekam Syndrome due to Homozygosity for a CCBE1 Mutation that does not Prevent Protein Expression (2016) Jackson CC, Best L, Lorenzo L, Casanova JL, Wacker J, Bertz S, Agaimy A, Harrer T Journal article HIV-Nef and ADAM17-Containing Plasma Extracellular Vesicles Induce and Correlate with Immune Pathogenesis in Chronic HIV Infection (2016) Lee JH, Schierer S, Blume K, Dindorf J, Wittki S, Xiang W, Ostalecki C, et al. Journal article The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial (2016) Dinges W, Girard PM, Podzamczer D, Brockmeyer NH, Garcia F, Harrer T, Lelievre JD, et al. Journal article PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis (2016) Faetkenheuer G, Jessen H, Stoehr A, Jung N, Jessen AB, Kuemmerle T, Berger M, et al. Journal article